[Recognizing patients at high risk for myocardial infarct]]

Area of Science:

• Cardiology
• Preventive Medicine
• Pharmacology

Context:

• Established benefits of antihypertensive and hypolipidemic medications in preventing coronary heart disease (CHD).
• Current international guidelines emphasize secondary prevention strategies for patients with manifest CHD.
• Guidelines recommend specific targets for blood pressure (<140/90 mm Hg) and LDL-cholesterol (<3 mmol/l or <2.6 mmol/l).

Purpose:

• To outline current recommendations for both secondary and primary prevention of coronary heart disease.
• To highlight the shift towards primary prevention in high-risk, presymptomatic individuals.
• To detail the risk factors necessary for calculating absolute myocardial infarction risk.

Summary:

• Controlled trials demonstrate the efficacy of antihypertensive and hypolipidemic drugs in CHD prevention.
• Secondary prevention focuses on target blood pressure and LDL-cholesterol levels in patients with existing CHD.
• Primary prevention strategies now target high-risk individuals using risk factor assessment (gender, age, family history, smoking, diabetes, lipids, blood pressure).
• Risk stratification employs epidemiological data-derived scores and algorithms to estimate annual myocardial infarction risk.

Impact:

• Informs clinical practice regarding evidence-based strategies for CHD prevention.
• Facilitates the identification and management of individuals at high risk for cardiovascular events.
• Supports the personalized approach to cardiovascular risk management through comprehensive risk factor evaluation.